# Stem Cell Transplantation for Patients With Multiple Myeloma

> **NCT01526096** · PHASE1 · COMPLETED · sponsor: **University of Chicago** · enrollment: 30 (actual)

## Conditions studied

- Myeloma

## Interventions

- **DRUG:** G-CSF
- **DRUG:** Plerixafor
- **PROCEDURE:** Apheresis
- **DRUG:** Melphalan
- **PROCEDURE:** Stem cell re-infusion
- **DRUG:** Basiliximab
- **DEVICE:** CliniMACS CD25 microbeads and cell sorter

## Key facts

- **NCT ID:** NCT01526096
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-12
- **Primary completion:** 2024-08-28
- **Final completion:** 2024-08-28
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01526096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01526096, "Stem Cell Transplantation for Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01526096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*